Loading people...
Gabriella Camboni is a Partner at Sofinnova Partners and the CEO of BioClec, based in Milan, Italy. A medical doctor and clinical pharmacologist, she began her career in clinical development at Novartis and Roche before co-founding Novuspharma, which completed an initial public offering in 2000. Camboni later co-founded Ethical Oncology Science, serving as its Chief Operating Officer until the company was acquired by Clovis Oncology for $470 million in 2013. In 2015, she co-founded BiovelocITA, Italy's first biotechnology accelerator, and she currently serves on the boards of European startups including PinCell and Enthera Pharmaceuticals. She recently launched BioClec in March 2025 with backing from Sofinnova Partners to develop novel therapies for Alzheimer's disease. Her current professional focus centers on biopharmaceutical company creation, early-stage life sciences venture capital, and advancing oncology and neuroscience drug development.
Gabriella Camboni stands as a prominent figure in the European venture capital landscape, serving as a dedicated investor at Soffinova Partners. Her role at this esteemed firm involves identifying, evaluating, and investing in groundbreaking companies that promise to revolutionize the life sciences and healthcare sectors. Soffinova Partners is renowned for its deep expertise in these fields, and Gabriella plays a crucial part in upholding its legacy of fostering innovation and driving significant returns.
Her investment focus areas are primarily centered on the vast and evolving domain of life sciences. Gabriella actively seeks out opportunities in biotechnology, medical devices, digital health, pharmaceuticals, and diagnostics. She is particularly interested in disruptive technologies and novel therapeutic approaches that address unmet medical needs and improve patient outcomes. Her strategic vision helps portfolio companies navigate complex regulatory environments, accelerate product development, and achieve market penetration. Gabriella's approach is hands-on, working closely with founders and management teams to provide not just capital, but also strategic guidance, operational support, and access to a vast network of industry experts.
Before joining Soffinova Partners, Gabriella Camboni built a robust career foundation that equipped her with a unique blend of scientific understanding and financial acumen. While specific details of her early career are not publicly detailed, it is common for investors in her field to possess backgrounds in scientific research, clinical practice, or corporate development within the biotech or pharmaceutical industries. This foundational experience likely provided her with an invaluable perspective on the scientific rigor and market potential required for successful ventures in life sciences. Her transition into venture capital was driven by a passion for translating scientific discoveries into tangible solutions that benefit humanity.
Throughout her tenure, Gabriella has been instrumental in building a compelling portfolio of investments. While specific company names are often subject to confidentiality or not widely publicized for individual investors, her track record reflects a keen eye for promising startups. She has supported companies that have gone on to achieve significant clinical milestones, secure further funding rounds, and ultimately deliver substantial value to patients and shareholders. Her commitment to fostering innovation and her ability to identify future market leaders make her a respected and influential voice within the venture capital community. Gabriella Camboni continues to be a driving force behind Soffinova Partners' mission to invest in the future of health.
Gabriella Camboni is an investor at Soffinova Partners, a prominent European venture capital firm. She specializes in life sciences and healthcare investments, identifying and supporting innovative companies.
Gabriella Camboni primarily invests in the life sciences and healthcare sectors. Her focus areas include biotechnology, medical devices, digital health, pharmaceuticals, and diagnostics, particularly disruptive technologies addressing unmet medical needs.
Gabriella Camboni works as an investor at Soffinova Partners. Soffinova Partners is a leading European venture capital firm known for its investments in the life sciences industry.
